Citurgia Biochemicals Reports ₹0.74 Cr Net Loss on Zero Revenue for FY26

Citurgia Biochemicals Limited has announced its audited financial results for the year ended March 31, 2026, revealing a net loss of ₹0.74 crore (₹74.25 lakh) on nil revenue from operations.

Reader Takeaway: Zero revenue and widening losses signal continued financial distress and operational inactivity for shareholders.

What just happened

The company reported zero revenue from operations for the financial year ending March 31, 2026. Despite this, total expenses amounted to ₹0.74 crore, primarily due to employee benefits and other operating costs. This resulted in a net loss of ₹0.74 crore, an increase from the ₹0.42 crore loss reported in the previous year.

Why this matters

These results highlight a critical situation for Citurgia Biochemicals, as the company is incurring costs without generating any income. The net worth has further deteriorated to a negative ₹7.73 crore, indicating that liabilities exceed assets. This raises concerns about the company's financial viability and its ability to conduct active business.

The backstory

For the year ended March 31, 2025, Citurgia Biochemicals also reported zero revenue and a net loss of ₹0.42 crore. The trend of nil revenue generation and persistent losses has continued into the latest fiscal year, with expenses slightly increasing.

What changes now

With zero revenue and negative net worth, the company's operational status remains a significant concern. Investors will be watching closely for any strategic changes or operational turnaround plans, although none are indicated in the current filing.

Risks to watch

The primary risks include the continued lack of revenue, the deepening negative net worth, and the ongoing operational expenses that further erode capital. The company's inability to generate income poses a fundamental threat to its existence.

Context metrics (time-bound)

• Revenue from Operations: ₹0 crore for FY26 vs. ₹0 crore for FY25.
• Net Loss: ₹0.74 crore for FY26 vs. ₹0.42 crore for FY25.
• Net Worth: ₹-7.73 crore as of March 31, 2026, vs. ₹-6.99 crore as of March 31, 2025.
• Total Assets: ₹10.47 crore as of March 31, 2026, vs. ₹10.76 crore as of March 31, 2025.

What to track next

Investors should closely monitor any future announcements regarding the company's operational status, potential asset sales, or any steps taken to address the negative net worth and lack of revenue.